FDA Inspection 1176535 — Prof. Bernardo Leon Rapoport
The FDA completed an inspection of Prof. Bernardo Leon Rapoport on Jul 14, 2022 in Johannesburg. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 14, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Johannesburg (South Africa)
Additional details
Clinical Investigator (CI)